Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
Toray Industries, Inc
Eli Lilly and Company
Seagen Inc.
Eli Lilly and Company
Dartmouth-Hitchcock Medical Center